搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
ophthalmologytimes
10 小时
Apellis Pharmaceuticals receives approval of pegcetacoplan (Syfovre) for treatment of ...
Pegcetacoplan (Syfovre) is now approved in Australia for treating geographic atrophy (GA) secondary to age-related macular ...
ophthalmologytimes
15 小时
Viralgen and Axovia Therapeutics partner to manufacture gene therapy for Bardet-Biedl Syndrome
The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...
ophthalmologytimes
15 小时
ARVO Foundation reveals 2025 Dr David L Epstein Award recipients
Recipients will be awarded $100,000 to support a collaborative project related to glaucoma ...
ophthalmologytimes
1 天
The path forward for oculomics and AI
The AI-READI project aims to establish fair, equitable, and ethical access to big data, enhancing artificial intelligence’s ...
ophthalmologytimes
1 天
Norlase receives FDA 510(k) clearance and CE mark for LYNX pattern scanning laser indirect ...
The company states LYNX is the world’s first and only pattern scanning laser indirect ophthalmoscope and is battery-powered ...
ophthalmologytimes
1 天
Tyrosine kinase inhibitor: An alternative treatment for non–small-cell lung cancer ...
Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...
ophthalmologytimes
2 天
Researchers identify 'triangle sign' as key diagnostic marker in ocular pathologies
The “Triangle sign” seen on ultrasound is a “distinctive and reliable” ultrasound feature for differentiating total choroidal ...
ophthalmologytimes
3 天
Dean McGee Eye Institute secures $800,000 in research and academic grants
Funds from the Inasmuch Foundation and The Samuel Roberts Noble Foundation will support the purchase of equipment, including ...
ophthalmologytimes
3 天
Pantheon Vision completes third pre-submission meeting with the FDA
The meetings support the company’s submission for its bioengineered corneal implants to eliminate corneal blindness.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈